VISCHER advised Battery Ventures in the transaction as Swiss counsel alongside White & Case. US private equity investor Battery Ventures acquired Swiss-based SaaS startup Avrios International...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised co-lead investors Samsara Biocapital and Lightspeed Venture Partners as their Swiss counsel. VISCHER advised ImmunOs. Walder Wyss advises Gimv. ImmunOs Therapeutics AG,...
You must be a Standard 1 Year member to access this content.
White & Case and Vischer advised Advanz Pharma on the deal. Advanz Pharma announced its acquisition of the ex-US business of Intercept Pharmaceuticals. ADVANZ PHARMA is a...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery and Vischer advised Mainova AG on the deal. Mainova executed the acquisition of a majority stake in energy service provider mobiheat GmbH. The...
You must be a Standard 1 Year member to access this content.
VISCHER advised the buyer on this transaction. Bär & Karrer acts as legal advisor to exceet Group in this transaction. A fund advised by AFINUM Management...
You must be a Standard 1 Year member to access this content.
Walder Wyss has advised the selling founders on the deal. Vischer advised the buyer. Nautilus, Inc. (NYSE: NLS), an innovation leader in home fitness, has acquired...
You must be a Standard 1 Year member to access this content.
VISCHER advised Haya Therapeutics SA on all legal issues related to the financing round. HAYA Therapeutics SA, a company developing precision medicines that target tissue and...
You must be a Standard 1 Year member to access this content.
VISCHER advised Haya Therapeutics SA on all legal issues related to the financing round. HAYA Therapeutics SA, a company developing precision medicines that target tissue and...
You must be a Standard 1 Year member to access this content.
VISCHER advises Relief Therapeutics regarding all legal aspects of this transaction. RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced...
You must be a Standard 1 Year member to access this content.
VISCHER advises Relief Therapeutics regarding all legal aspects of this transaction. RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced...
You must be a Standard 1 Year member to access this content.
VISCHER advised Loomis. Loomis, a Sweden-based and listed provider of cash handling services for banks, retailers and other commercial clients, has, through its wholly owned subsidiary...
You must be a Standard 1 Year member to access this content.
